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Inability to Decarboxylate Lysine as a Presumptive Marker To Identify Shiga
Toxin-Producing Escherichia coli Strains of Serogroup O111
Shiga toxin (Stx)-producing Escherichia coli (STEC) strains
are important agents of gastrointestinal disease in humans,
particularly since such infections may result in a life-threaten-
ing complication such as the hemolytic-uremic syndrome (HUS)
(10, 12). While numerous outbreaks have been related to E. coli
serotype O157:H7, several other serotypes, including O111:NM
(nonmotile) and O111:H8, are well-recognized causes of bloody
diarrhea and HUS in different parts of the world (1, 3, 4). In
Brazil, although human STEC infections are in general re-
stricted to sporadic cases of nonbloody diarrhea, O111:NM
and O111:H8 represent the most frequent serotypes so far
identified (8; T. M. I. Vaz et al., submitted for publication).
Other important O111 serotypes, including O111:H2 and
O111: NM, classified as enteropathogenic E. coli (EPEC) have
been a leading cause of infantile diarrhea in our country for
many years (7). Moreover, serotypes O111:H9 and O111:H12
were shown to belong to other diarrheagenic E. coli categories,
i.e., atypical EPEC and enteroaggregative E. coli (EAEC),
respectively (2).
Therefore, identification of O111 strains only by serogroup-
ing, as performed in most laboratories, does not characterize
properly the etiologic agent. Some biochemical characteristics
have been proven useful for screening O157:H7 STEC strains
(5), but the lack of a distinct phenotype in non-O157 STEC
strains, except the production of Stx, can be considered a
drawback in the isolation and identification of this group of
bacteria in most clinical routine analyses.
In a previous study conducted in our laboratory (8), we
interestingly observed that O111:NM STEC strains fail to de-
carboxylate lysine (6). Afterwards, this observation was con-
firmed in a large number of O111 STEC strains (Vaz et al.,
submitted). Thus, these results led us to examine our labora-
tory collection of O111 E. coli strains belonging to the different
pathogenic categories for the ability to decarboxylate lysine.
We observed that none of the O111 STEC strains decarboxyl-
ate this amino acid, whereas lysine decarboxylation was posi-
tive in 435 of the 438 (99.3%) E. coli O111 strains character-
ized as EPEC, atypical EPEC, or EAEC or as belonging to an
as-yet-undefined pathogenic group (Table 1). Moreover, the
inability to decarboxylate lysine seems to be a characteristic of
O111 STEC strains that distinguishes it from other important
STEC serotypes (Vaz et al., submitted).
The ability to metabolize -phenylpropionic acid (PPA) has
been demonstrated to be of significant value in detecting
EPEC strains, particularly of serogroup O111, since O111
strains belonging to different pathogenic categories were PPA
negative (9, 11). Thus, according to the results described in the
present study, the use of lysine decarboxylation in association
with PPA will permit the identification of STEC and EPEC
strains, respectively, among E. coli strains of the O111 serogroup.
In conclusion, the lysine decarboxylation assay, which is a
simple, routine biochemical assay, can be an important tool
and can aid in the presumptive identification of O111 STEC
strains, especially in clinical laboratories that usually do not
include assays to detect Stx toxins or gene sequences.
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TABLE 1. Lysine decarboxylation by E. coli O111 strains
belonging to different diarrheagenic categories
Diarrheagenic
category
No. of
strains Flagellar antigen (H)
a
No. (%) of strains
that decarboxy-
late lysine
STECb 28 H8, NM 0
EPEC 382 H2, H6, H10, NM, NT 380 (99.5)
Atypical EPEC 14 H2, H9, H33, NM, NT 13 (92.8)
EAEC 10 H12 10 (100)
Unknown 32 H4, H9, H10, H12, H15,
H28, H31, H45, NM, NT
32 (100)
a NM, nonmotile; NT, nontypeable.
b Except for 2 strains isolated from cattle all the others were of human origin.
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